UK markets open in 2 hours 22 minutes

Gilead Sciences, Inc. (GILD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
60.03+0.53 (+0.89%)
At close: 1:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close59.50
Open59.64
Bid0.00 x 1000
Ask0.00 x 800
Day's range59.28 - 60.05
52-week range57.04 - 85.97
Volume4,921,858
Avg. volume9,418,068
Market cap75.249B
Beta (5Y monthly)0.55
PE ratio (TTM)59.61
EPS (TTM)1.01
Earnings date02 Feb 2021 - 08 Feb 2021
Forward dividend & yield2.72 (4.53%)
Ex-dividend date14 Dec 2020
1y target est73.72
  • Is Gilead Sciences a Great Dividend Stock?
    Motley Fool

    Is Gilead Sciences a Great Dividend Stock?

    When you think about dividend stocks, biotechs probably don't immediately come to mind. Gilead Sciences' (NASDAQ: GILD) dividend program especially stands out. The company arguably offers the best dividend of any biotech.

  • Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
    Motley Fool

    Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?

    Gilead Sciences (NASDAQ: GILD) started the year strong. As a result, while the rest of the stock market slid, Gilead did just the opposite. To make matters worse, the World Health Organization (WHO) recently advised against using remdesivir as a treatment for COVID-19.

  • Gilead's New CEO Is Going All-In on Acquisitions
    Motley Fool

    Gilead's New CEO Is Going All-In on Acquisitions

    Daniel O'Day has made increasingly larger deals in an effort to improve the company's portfolio of cancer drugs.